Evidence map›Paper›PMID 41472846›Full record

ArticleiMeta2025

High-throughput generic single-entity sequencing using droplet microfluidics.

Guoping Wang, Liuyang Zhao, Yu Shi, Fuyang Qu, Yanqiang Ding, Weixin Liu, Changan Liu, Gang Luo, Meiyi Li, Xiaowu Bai and 5 more

Abstract read
In one paragraph

Article in iMeta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Guoping WangInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.ORCID https://orcid.org/0000-0002-2635-6932
Liuyang ZhaoInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.
Yu ShiInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.
Fuyang QuDepartment of Biomedical Engineering The Chinese University of Hong Kong Hong Kong SAR China.
Yanqiang DingInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.
Weixin LiuInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.
Changan LiuInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.
Gang LuoDepartment of Electronic Engineering The Chinese University of Hong Kong Hong Kong SAR China.
Meiyi LiInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.
Xiaowu BaiInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.
Luoquan LiDepartment of Biomedical Engineering The Chinese University of Hong Kong Hong Kong SAR China.
Luyao WangInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.
Chi Chun WongInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.
Yi-Ping HoDepartment of Biomedical Engineering The Chinese University of Hong Kong Hong Kong SAR China.ORCID https://orcid.org/0000-0002-2052-9724
Jun YuInstitute of Digestive Diseases and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences The Chinese University of Hong Kong Hong Kong SAR China.ORCID https://orcid.org/0000-0001-5008-2153

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell sequencing has revolutionized our understanding of cellular heterogeneity by providing a micro-level perspective in the past decade. While heterogeneity is fundamental to diverse biological communities, existing platforms are primarily designed for eukaryotic cells, leaving significant gaps in the study of other single biological entities, such as viruses and bacteria. Current methodologies for single-entity sequencing remain limited by low throughput, inefficient lysis, and highly fragmented genomes. Here, we present the Generic Single-Entity Sequencing (GSE-Seq), a versatile and high-throughput framework that overcomes key limitations in single-entity sequencing through an integrated workflow. GSE-Seq combines (1) one-step generation of massive barcodes, (2) degradable hydrogel-based in situ sample processing and whole genome amplification, (3) integrated in-droplet library preparation, and (4) long-read sequencing. We applied GSE-Seq to profile viral communities from human fecal and marine sediment samples, generating thousands of high-quality single-entity genomes and revealing that most are novel. GSE-Seq identified not only dsDNA and ssDNA viruses, but also hard-to-detect giant viruses and crAssphages. GSE-Seq of bacterial genomes also revealed putative novel bacterial species, validating the versatility of this platform across different microbial kingdoms. Collectively, GSE-Seq represents a robust framework that addresses persistent challenges in high-throughput profiling for generic applications and holds immense promise for single-cell deconvolution of diverse biological entities.

Indexed as

droplet microfluidicslong‐read sequencingmetagenomicsmicrobial dark mattersingle‐cell genomicssingle‐virus genomics

Identifiers

PMID41472846
PMCPMC12747555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.